Friday 15 August 2014

Global Intranasal Drug Delivery Market 2014-2018

Global Intranasal Drug Delivery Market 2014-2018 is a new market research publication announced by Reportstack. Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. The nose is considered to be an ideal administrative route for needle-free vaccination and systematic drug delivery. Continuous technological advancement is being made in intranasal drug delivery product to achieve efficient treatment facility. Intranasal drug delivery system plays a major role in improving the quality of the life of patients, by providing an easy mode of drug administration for patients on long-term therapy, as well as low risk of overdose and enhanced bioavailability.

The analysts forecast that the Global Intranasal Drug Delivery market to grow at a CAGR of 2.92 percent over the period 2013-2018. This report covers the present scenario and the growth prospects of the Global Intranasal Drug Delivery market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of the following intranasal drug delivery systems:
• Nasal spray
• Nasal drop
• Nasal powder
• Nasal gel
• Nasal vaccine
The report, the Global Intranasal Drug Delivery market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Intranasal Drug Delivery market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Becton, Dickinson and Company
• GlaxoSmithKline
• Johnson & Johnson
• Novartis
Other Prominent Vendors

• Actiza Pharmaceutical
• Aptar Group
• Korten Pharmaceuticals
• OptiNose
• Patheon
• Vee Remedies
• Zymeth Wellness
Market Driver
• Increase in Aging Population
• For a full, detailed list, view our report
Market Challenge
• Risk of Over Dosage and Side Effects
• For a full, detailed list, view our report
Market Trend
• Increased Adoption of Non-invasive Products
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?


Companies Mentioned

Becton, Dickinson and Company, GlaxoSmithKline, Johnson & Johnson, Novartis, Actiza Pharmaceutical, Aptar Group, Korten Pharmaceuticals, OptiNose, Patheon, Vee Remedies and Zymeth Wellness

To view the table of contents and know more details please visit Global Intranasal Drug Delivery Market 2014-2018.

No comments:

Post a Comment